Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
Digital
Company news: Digital health edition
May 15, 2012
Physician social network adoption was flat from 2011-2012, a survey says, and Everyday Health gets a nom for a daytime Emmy
Consumers getting comfortable with social media as a health resource
Matthew Arnold
April 17, 2012
Around a third of US adults use social media as a health resource, according to a survey by PricewaterhouseCoopers - whether seeking out medical info, sharing symptoms and experiences or rating drugs, devices, doctors, hospitals and health plans.
With online doctor quiz, edugaming dons lab coat
Matthew Arnold
April 03, 2012
Could an online quiz be the future of continuing medical education? In a twist on the "edu-gaming" phenomenon, Cleveland Clinic and physician site MDLinx aim to answer that question with The Smartest Doc, a daily one-minute quiz that aims to keep doctors up to date on the medical literature by appealing to their competitive spirit.
Sermo looks for new leaders—and profitability
Matthew Arnold
March 20, 2012
Sermo is searching for a CEO and a medical advisory board since the physician online community's founder, Dr. Daniel Palestrant, and chief medical officer, Dr. Adam Sharp, left in November to launch a new startup called Par8o.
GSK seeks to span digital divide with social/digital dragnet
Deborah Weinstein
March 19, 2012
GlaxoSmithKline is souping up its social media monitoring with a digital strategy it says will create processes that are standard enough to streamline communications, but flexible enough to meet local requirements.
Novo Nordisk launches "robust" Hispanic FlexPen play
Matthew Arnold
February 27, 2012
Novo Nordisk has launched a big integrated Spanish-language marketing campaign for its FlexPen insulin delivery device - one that Univision calls "the most robust ever" in Hispanic media for the diabetes sector.
Industry group releases digital best practices
Matthew Arnold
February 06, 2012
Weary of FDA foot-dragging on digital and social media guidance for pharmas, a group of 60-some industry digerati have put together guidelines of their own.
P&G signals plans to cut ad costs by shifting to digital media
Matthew Arnold
February 01, 2012
Procter & Gamble is looking to lower its promotion costs by leaning more on digital media, Chairman and CEO Bob McDonald told analysts in an earnings call.
Victoza effort featuring Southern cuisine queen Deen draws flak
Matthew Arnold
January 17, 2012
Novo Nordisk is courting controversy with a Victoza-branded type 2 diabetes education campaign featuring Southern-fried celebrity chef Paula Deen and her sons.
WebMD calls off sales plans, CEO steps down amid ugly forecast for 2012
Matthew Arnold
January 10, 2012
WebMD scrapped plans for a possible sale and announced that president and CEO Wayne Gattinella is stepping down after 11 years in that role.
Healthline lands Drugs.com ad sales deal
Matthew Arnold
January 05, 2012
Healthline Networks has secured a deal with Drugs.com giving it exclusive rights to sell consumer ads on the site, which boasts 8.8 million unique visitors per month.
Merck takes stake in Physicians Interactive
Matthew Arnold
January 05, 2012
Merck's Global Health Innovation Fund (GHIF) is investing up to $17 million in Physicians Interactive, a company that develops digital products for doctors such as e-sampling and interactive education programs.
A targeted mobile effort for a thermometer shadows the flu
Matthew Arnold
January 04, 2012
Mobile campaigns are getting increasingly targeted through layering of identifiers like location, age and gender. An effort for a new thermometer serves ads only to expecting moms and those with children under five within two miles of a store selling the device and only when influenza is running rampant where they live.
Behind WebMD's PE courtship, a business model under pressure
Matthew Arnold
December 23, 2011
WebMD's talks with private equity firms come amid an advertising slump, and going private could buy the firm time to retool its business model while insulating it from activist investors like Carl Icahn.
Bon Jovi enlists in Advil's battle with Tylenol
Matthew Arnold
December 21, 2011
Jon Bon Jovi is the latest celebrity pitchman for Pfizer Consumer Healthcare's Advil.
Consumers may be savvier, less fearful about online privacy and advertising than you think
Matthew Arnold
October 27, 2011
Consumers are as worried about online privacy as they are about terrorism, but marketers tracking their surfing habits or mining their emails for insights is the least of their worries, according to a survey by McCann Truth Central.
Boehringer's Pharma-ville could salve industry's bad reputation
James Chase
October 26, 2011
Boehringer Ingelheim is hoping to create a new Facebook phenomenon with the development of a pharma civilization game that could give industry reputation a shot in the arm.
Study of diabetes social networks finds an advertising Wild West
Matthew Arnold
October 13, 2011
More than a quarter of posts on Facebook sites for people with diabetes are promotional in nature, many touting products unapproved by the FDA, according to an analysis of diabetes-focused social networks.
Friends and family top health influencers, says survey
Matthew Arnold
October 12, 2011
Underscoring the importance of social media in public health, patients say friends and family are as responsible for their health as are medical professionals, according to Edelman's 2011 Health Barometer study.
Advertising as dating game: It's the brand.com where things get serious
Matthew Arnold
October 05, 2011
A survey by Yahoo! and advertising giant BBDO says advertisers need to raise their game in "owned media" like brand.com sites to woo consumers.
Merck web widget points to future adherence fix
Matthew Arnold
October 04, 2011
Asking consumers to gauge their risk for non-adherence, Merck is deploying a one-minute survey dubbed the Adherence Estimator that may be the way forward for keeping patients on-treatment.
Lipitor.com gets Bad Ad slap for cross-promotion sans risk info
Matthew Arnold
September 06, 2011
Pfizer's Lipitor website touted the efficacy of Caduet, Chantix and Norvasc but failed to balance those claims with risk info for the drugs, according to an "untitled letter" from FDA's Division of Drug Marketing, Advertising and Communication (DDMAC).
EMD Serono brings back "Birds & Bees" infertility effort
Matthew Arnold
July 27, 2011
EMD Serono refreshed its "Birds & Bees" fertility issues awareness campaign with a Facebook page and a music video.
Ethnically insensitive Summer's Eve ads draw eyeballs and brickbats
Matthew Arnold
July 20, 2011
A feminine hygiene brand known for its boffo advertising is back with an anatomically-explicit ad campaign that's generating tons of publicity but also charges of racism.
FDA guidance exempts most pharma apps from scrutiny
Matthew Arnold
July 19, 2011
FDA issued draft guidance on mobile medical apps, focusing narrowly on those programs that augment regulated medical devices or turn mobile devices into medical devices.
Pharma digerati push for online guidelines
Matthew Arnold
June 16, 2011
Frustrated by FDA inaction on guidance for digital marketing and social media, a host of industry players are banding together to form a nonprofit that can hammer out consensus on a way forward.
Lilly refreshes patient ed portal, launching YouTube channel
Matthew Arnold
June 15, 2011
Eli Lilly & Co. refreshed its Lilly for Better Health program with a multichannel platform and a YouTube channel.
Facebook: pharmas must enable comments by August 15
Matthew Arnold
May 24, 2011
Facebook sales reps told pharmas last week that they can no longer disable commenting on their non-brand-specific pages, potentially exposing them to flame warriors, spammers, adverse events reports and discussion of off-label uses that might call down the wrath of DDMAC.
Seeking "savoir-faire," Publicis buys Rosetta for $575 million
Matthew Arnold
May 17, 2011
Publicis is padding its digital health agency supergroup with a $575 million-plus acquisition of Rosetta Marketing Group.
Social media gurus Gwee and Monseau move on to new jobs
Matthew Arnold
May 12, 2011
Two of the drug industry's brightest minds in social media, Shwen Gwee and Marc Monseau, are changing jobs, with Gwee leaving Vertex for Edelman and Monseau exiting J&J to open his own firm.
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Wolters Kluwer deals health analytics unit to private equity firm
Pharmas are from Mars, Payers are from Venus
Study: Young Latinas are key decision makers, prefer English
Coach vs. cancer in BMS-backed awareness effort
Indian conglomerate buys Manhattan Research parent for $635m
No-see docs are know-nothings when it comes to new drug info, study suggests
How CDC's hep.-C testing advice benefits drugmakers now
National plan seeks Alzheimer's treatment by 2025
Study: Young Latinas are key decision makers, prefer English
Wolters Kluwer deals health analytics unit to private equity firm
Pharmas are from Mars, Payers are from Venus
Indian conglomerate buys Manhattan Research parent for $635m
No-see docs are know-nothings when it comes to new drug info, study suggests
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Coach vs. cancer in BMS-backed awareness effort
National plan seeks Alzheimer's treatment by 2025
E-prescriptions boost adherence data
No-see docs are know-nothings when it comes to new drug info, study suggests
E-prescriptions boost adherence data
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Study: Young Latinas are key decision makers, prefer English
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Sales forces shrank in 2011, but not everywhere
National plan seeks Alzheimer's treatment by 2025
Popular Topics
Acquisition
Adherence
Agency
App
Celebrity
Clinical Trial
Co-Marketing
Conflict Of Interest
Diabetes
Diagnostics
Digital
Direct To Consumer (DTC)
Disease Awareness
Downsize
Education & Awareness
FDA
Government
Guidance
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Sales Force